Can a healthcare provider prescribe Augmentin (amoxicillin/clavulanate) for a skin infection and what is the recommended dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin for Skin Infections: Prescribing and Dosing

Yes, healthcare providers can prescribe Augmentin (amoxicillin-clavulanate) for skin infections, and the standard adult dose is 875 mg/125 mg orally every 12 hours for more severe infections or 500 mg/125 mg every 8-12 hours for less severe infections. 1

When to Prescribe Augmentin for Skin Infections

Primary Indications

  • Human bite wounds are the clearest indication for Augmentin, as the drug provides coverage against Eikenella corrodens, streptococci, S. aureus, and multiple anaerobic organisms that commonly cause these infections 2
  • Animal bite wounds also warrant Augmentin therapy, with dosing at 875 mg/125 mg twice daily orally 2
  • Mixed infections involving both aerobic and anaerobic bacteria benefit from Augmentin's broad spectrum coverage 3, 4

Secondary Considerations

  • Augmentin is particularly valuable when beta-lactamase-producing organisms are suspected, as clavulanic acid inhibits these enzymes and restores amoxicillin activity 3
  • For infected eczema, infected trauma wounds, and leg ulcers, Augmentin demonstrated 94% response rates in clinical studies 3
  • When amoxicillin-resistant Staphylococcus aureus is present (but not MRSA), Augmentin provides effective coverage 3

Dosing Recommendations

Adults

For more severe skin and soft tissue infections:

  • 875 mg/125 mg orally every 12 hours 1
  • This is the preferred regimen for respiratory tract infections and more severe skin infections 1

For less severe infections:

  • 500 mg/125 mg every 12 hours OR 250 mg/125 mg every 8 hours 1
  • The every 12-hour regimen is associated with significantly less diarrhea 1

Administration:

  • Take at the start of meals to enhance clavulanate absorption and minimize gastrointestinal intolerance 1

Pediatric Patients (≥12 weeks/3 months)

For more severe infections:

  • 45 mg/kg/day (based on amoxicillin component) divided every 12 hours using the 200 mg/5 mL or 400 mg/5 mL suspension 1

For less severe infections:

  • 25 mg/kg/day divided every 12 hours 1

Children ≥40 kg:

  • Dose according to adult recommendations 1

Critical Pitfalls to Avoid

Formulation Errors

  • Never substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet - they contain the same amount of clavulanic acid (125 mg), making them non-equivalent 1
  • Different formulations contain different ratios of amoxicillin to clavulanic acid and are not interchangeable 1

MRSA Coverage

  • Augmentin does NOT cover MRSA 2
  • For purulent infections with suspected MRSA (history of MRSA, injection drug use, failed initial therapy, or systemic signs), choose alternative agents like trimethoprim-sulfamethoxazole, doxycycline, or clindamycin instead 2

Storage and Compliance

  • In hot climates, improper storage (such as leaving medication in a hot car) can degrade the antibiotic and lead to treatment failure 5
  • Counsel patients on proper storage and the importance of completing the full course 5

Expected Outcomes and Monitoring

Efficacy

  • Clinical success rates of 96-97% for skin and soft tissue infections have been demonstrated in hospitalized patients 4
  • Bacteriologic cure rates of 72-76% are typical 6

Adverse Effects

  • Diarrhea (3.6-9%) and nausea (9%) are the most common side effects 3, 4
  • Skin reactions (3-4.8%) may occur 3, 4
  • The every 12-hour dosing regimen significantly reduces diarrhea compared to every 8-hour dosing 1

Duration of Therapy

  • Typical duration is 7-10 days depending on clinical response 2
  • Clinical improvement should be evident within 48-72 hours of initiating therapy 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.